Jennifer K. Simpson - 28 Feb 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
28 Feb 2022
Transactions value $
$0
Form type
4
Filing time
02 Mar 2022, 17:05:30 UTC
Previous filing
17 Dec 2021
Next filing
01 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Stock Option (right to buy) Award $0 +11,200 $0.000000 11,200 28 Feb 2022 Common Stock 11,200 $47.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option fully vests on February 28, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.